Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank7
3Y CAGR-31.7%
5Y CAGR-0.8%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-31.7%/yr
vs +35.7%/yr prior
5Y CAGR
-0.8%/yr
Recent deceleration
Acceleration
-67.4pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.36M | -21.6% |
| 2024 | $23.41M | -8.9% |
| 2023 | $25.71M | -55.4% |
| 2022 | $57.60M | +98.3% |
| 2021 | $29.05M | +51.7% |
| 2020 | $19.14M | -4.7% |
| 2019 | $20.09M | +18.3% |
| 2018 | $16.99M | -38.4% |
| 2017 | $27.59M | -22.2% |
| 2016 | $35.48M | - |